Left Ventricular End-Diastolic Pressure and B-Type Natriuretic Peptide Levels Guidance of Low-Dose Furosemide Treatment to Prevent Contrast-Induced Nephropathy in Patients with Percutaneous Coronary Intervention: A Randomized Controlled Trial
Objective. We aimed to explore the preventive effect of low-dose furosemide administration guided by left ventricular end-diastolic pressure (LVEDP) and B-type natriuretic peptide (BNP) based on adequate hydration on contrast-induced nephropathy (CIN) in patients with percutaneous coronary intervent...
Guardado en:
Autores principales: | Guoqiang Gu, Demin Liu, Rui Lu, Wei Cui |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi-Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/924c0d3862a542df8be15bfd48f56344 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Left Ventricular End-Diastolic Diameter and Cardiac Mortality in Duchenne Muscular Dystrophy
por: Segawa K, et al.
Publicado: (2020) -
Contrast induced nephropathy with ultra-low contrast percutaneous coronary intervention under intravascular ultrasound guidance in patients of chronic kidney disease
por: Raushan Ranjan, et al.
Publicado: (2021) -
Possible diverse contribution of coronary risk factors to left ventricular systolic and diastolic cavity sizes
por: Kenichiro Suzuki, et al.
Publicado: (2021) -
The impact of obesity on left ventricular hypertrophy and diastolic dysfunction in children and adolescents
por: Joanna Bartkowiak, et al.
Publicado: (2021) -
Sex-specific predictors of left ventricular diastolic dysfunction in untreated hypertension
por: Jaroch J, et al.
Publicado: (2016)